The KIT protein is a receptor tyrosine kinase of the platelet derived growth factor (PDGF) receptor family which regulates haematopoiesis, melanogenesis and gut and germ cell development. KIT regulates these diverse processes, at least in part, by inhibiting apoptosis. We have previously found that KIT can suppress p53-mediated apoptosis. The mechanism by which KIT suppresses apoptosis is, however, uncharacterized. Neither is it clear how p53 induces apoptosis. In this report we ®nd that p53-dependent apoptosis proceeds through a pathway involving depolarization of the mitochondrial electropotential gradient (DC m ) and the generation of reactive oxygen species (ROS). KIT activation suppresses p53-induced apoptosis in the mouse DP16 Friend erythroleukemia cell line by preventing DC m depolarization and ROS generation. Thus, the KIT kinase prevents apoptosis by regulating mitochondrial function and cellular redox state.
Introduction
The KIT protein, the product of the mouse dominant white spotting locus (W), is a tyrosine kinase of the platelet derived growth factor receipt (PDGFR) family (Bernstein et al., 1990) . KIT is a membrane-bound protein with an intracellular kinase domain and an extracellular ligand binding domain (van der Geer et al., 1994) . The ligand for the KIT protein is Steel factor, the protein product of the mouse Steel locus (Sl) (Besmer, 1991) . Activation of KIT by binding to Steel factor leads to KIT dimerization and auto-and trans-phosphorylation of the receptor (Lev et al., 1992) . Steel factor-induced tyrosine phosphorylation of KIT leads to the activation and phosphorylation of other signaling molecules, including PI-3 kinase, SHC, PTP-1C and PLC-g .
KIT and Steel both have important roles in regulating mouse development. Defects in the KIT or Steel genes in W and Sl mice lead to a pleiotropic phenotype, including severe macrocytic anemia, infertility, gut dysfunction and pigmentation defects Besmer, 1991; Huizinga et al., 1995) . Haematopoeitic cells from W and Sl mice also show an increased sensitivity to g-radiation (Yee et al., 1994; Neta et al., 1993) . The developmental abnormalities of W and Sl mice and their cellular sensitivity to g-radiation likely stems from the ability of KIT to suppress apoptosis. Activation of KIT can suppress apoptosis in several haematopoeitic cell lines, including natural killer cells, mast cells, and many leukemia lines (Yee et al., 1994; Shui et al., 1995; Carson et al., 1994; Caceres-Cortes et al., 1994; Iemura et al., 1994; Mekori et al., 1993) .
Apoptosis is a tightly regulated mechanism of cell death, distinct from necrosis, involving plasma membrane blebbing, cell shrinkage, chromatin condensation and DNA degradation (Wyllie et al., 1980) . Apoptosis can be activated by multiple, independent signaling pathways, including Fas and TNF receptor activation, growth factor deprivation, steroids and DNA damage (Vaux and Strasser, 1996; Reed, 1994; Lee and Bernstein, 1995) . These diverse signals converge on a common eector pathway involving the alteration of mitochondrial function (Henkart and Grinstein, 1996; Kroemer et al., 1997) .
Mitochondria are key apoptotic regulators. Mitochondrial extracts are sucient to induce apoptosis-like chromatin condensation and nuclear disintegration in Xenopus sperm nuclei (Newmeyer et al., 1994) . During apoptosis, mitochondrial cytochrome c is released into the cytoplasm (Liu et al., 1996) , leading to apoptosis through the activation of the caspase family of cysteine proteases (Kluck et al., 1997b; Salvesen and Dixit, 1997; Li et al., 1997) . One of the mechanisms controlling cytochrome c release from mitochondria is the mitochondrial permeability transition (PT) pore, a multi-protein complex which controls the mitochondrial transmembrane potential (DC m ) (Zoratti and Szabo, 1995; Kroemer et al., 1997) . The DC m results from the translocation of protons from the mitochondrial matrix across the inner mitochondrial membrane during respiration. Opening of the PT pore and subsequent depolarization of DC m is among the earliest detectable events during ceramide, TNFa, steroid, Fas, SV40 and g-radiation-induced apoptosis (Zamzami et al., 1995; Castedo et al., 1996; Marchetti et al., 1996b; Vayssiere et al., 1994) . Drugs which depolarize DC m induce apoptosis, and agents which stabilize DC m inhibit apoptosis, suggesting that apoptosis is regulated by PT pore opening and DC m depolarization . One of the mechanisms by which the bcl-2 proto-oncogene inhibits apoptosis is by stabilizing the DC m (Adachi et al., 1997; Shimizu et al., 1996) .
Another facet of mitochondrial control of apoptosis is reactive oxygen species (ROS) generation (Zamzami et al., 1995) . ROS are both activators and eectors of apoptosis (Buttke and Sandstrom, 1994) . As apoptosis eectors, ROS can damage membranes through lipid peroxidation and cause DNA strand breaks. Most cellular ROS are products of mitochondrial metabolism and inhibitors of mitochondrial ROS generation inhibit the apoptosis induced by TNFa and dexamethasone (Schulze-Ostho et al., 1992 Zamzami et al., 1995) . The bcl-2 proto-oncogene can inhibit apoptosis, at least in part, through the inhibition of ROS production (Kane et al., 1993) . ROS production may be linked to DC m depolarization (Henkart and Grinstein, 1996; Kroemer et al., 1997) .
We, and others, have previously found that activation of the KIT kinase can suppress the apoptosis induced by the p53 tumor suppressor (Abrahamson et al., 1995; Lin and Benchimol, 1995) . The p53 tumor suppressor is a transcription factor that is a powerful activator of apoptosis (Levine et al., 1991; Lee and Bernstein, 1995) . p53 is required for the apoptosis induced by g-radiation and the anti-cancer drugs adriamycin, etoposide and 5-¯urouracil (Lee and Bernstein, 1993; Lowe et al., 1993a, b; Clarke et al., 1993) . The molecular mechanism by which p53 induces apoptosis is not yet clear; neither is it apparent how KIT suppresses apoptosis. In this report we ®nd that KIT suppresses apoptosis by preventing p53-induced depolarization of DC m and ROS production. Thus, the KIT membrane receptor is likely to inhibit apoptosis by regulating mitochondrial function and cellular redox state.
Results

KIT activation suppresses p53-dependent apoptosis
We have previously derived a DP16 Friend erythroleukemia cell line, Ts-DP16, which undergoes p53 dependent apoptosis at 328C (Abrahamson et al., 1995) . Ts-DP16 expresses a temperature sensitive variant of the mouse p53 gene, p53 vall35 , under the control of the genomic p53 promoter. At 328C, the p53 vall35 protein undergoes a conformational change and activates apoptosis (Michalovitz et al., 1990) . The parental DP16 cell line expresses neither wild type nor mutant p53 protein (Mowat et al., 1985) .
As shown in Figure 1a , incubation of Ts-DP16 for 24 h at 328C leads to death of over 50% of the cells. This death is inhibited by Steel factor, the KIT ligand ( Figure 1a ). After 24 h at 328C in 100 ng/ml of Steel factor, 90% of the Ts-DP16 cells are still viable. As shown in Figure 1b , Steel also suppresses the nucleosomal laddering which occurs following the incubation of Ts-DP16 at 328C. Ts-DP16 cells incubated with 100 ng/ml of Steel show no evidence of laddering after 24 h at 328C (Figure 1b) . We have previously found that KIT has no eect on the ability of p53 to transactivate several target genes in Ts-DP16 following temperature shift to 328C (Abrahamson et al., 1995) . Thus, KIT activation is unlikely to suppress p53-dependent apoptosis by inhibiting p53 function directly. Rather, KIT must target an apoptotic regulator`downstream' of p53.
KIT activation suppresses mitochondrial membrane depolarization
Mitochondria have a central role in apoptotic regulation. Opening of the permeability transition (PT) pore and depolarization of the mitochondrial transmembrane potential (DC m ) is an invariant feature of multiple forms of apoptosis. Thus, mitochondria might be important targets for KIT during the inhibition of p53-dependent apoptosis. To determine if KIT activation has any eect on mitochondrial function during apoptosis in Ts-DP16, we have measured changes in DC m during apoptosis in Ts-DP16 with and without Steel factor. DC m is measured using the dye Rhodamine 123 (Rh123), a¯uorophore whose magnitude of¯uorescence increases as the mitochondrial transmembrane potential increases.
A¯ow cytometric pro®le of Ts-DP16 at 378C and 328C is shown in Figure 2a 
SS
hi phenotype is a common feature of many cells in the early stages of apoptosis (Vayssiere et al., 1994) . As shown in Figure 2c , low DC m cells in Ts-DP16 at 4 h following the temperature shift, precedes the ®rst detection of nucleosomal laddering in the Ts-DP16 population at 328C. Thus, an early step in the induction of p53-mediated apoptosis is a reduction in DC m .
After a 24 h incubation at 328C, all Ts-p53-DP16 cells have substantially lower Rh123 staining than wild type cells (Figure 3a) , indicative of lower DC m . As shown in Figure 3b , the addition of the protonophore carbonyl cyanide m-chlorophenyl-hydrazone (ClCCP) to Ts-DP16 cells 0 and 24 h after 328C incubation results in a marked reduction of Rh123 staining in both cell types. ClCCP dissipates the DC m by making the mitochondrial membrane permeable to protons. Thus, the dierence is Rh123 staining between the apoptotic and non-apoptotic DP16 cells is the result of a dierence in DC m (Figure 3a ). After an 8 h incubation at 328C, two populations of Ts-DP16 cells are apparent, those with high DC m and low DC m ( Figure 3c ). As described in Figure 2 , the high and low DC m cells represent normal and apoptotic cells respectively. As shown in Figure 3d , KIT activation (through the addition of 100 ng/ml of Steel factor) prevents the appearance of Ts-DP16 cells with low DC m . As shown in Figure 3e , cells with low DC m are ®rst detectable 2 ± 4 h following incubation at 328C, with 90% of Ts-DP16 having low DC m 24 h after temperature shift. One hundred ng/ml of Steel factor, but not 10 ng/ml of Steel factor prevents the appearance of DC m low cells (Figure 3d ). We have previously found that 100 ng/ml of Steel factor is required for maximal apoptotic suppression (Abrahamson et al., 1995) . Taken together, Figures 2 and 3 suggest that KIT inhibits apoptosis by preventing depolarization of the DC m .
KIT activation prevents p53-dependent ROS production
One of the eects of mitochondrial membrane depolarization during apoptosis is the intracellular production of reactive oxygen species (ROS). As shown in Figure 4a , p53-dependent apoptosis in Ts-DP16 is accompanied by an increase in ROS, as measured by an increase in 2',7'-dichlorodihydrofluoresceindiacetate (DCF)¯uorescence, ®rst detectable 2 ± 4 h after the temperature shift to 328C. There is some ROS production in parental DP16 cells grown at 328C (Figure 4a ), though this is not associated with apoptosis and may result from cellular stress associated with washing. Activation of KIT through addition of Steel factor prevents the accumulation of ROS in Ts-DP16 grown at 328C (Figure 4b ). Maximal inhibition of ROS production occurs with 100 ng/ml of Steel factor, the dose required for inhibition of mitochondrial membrane depolarization and apoptosis suppression.
KIT aects DC m independently of bcl-2 and Bax protein levels
Ectopic expression of the bcl-2 protein inhibits apoptosis and bcl-2 expression can prevent DC m depolarization and ROS production (Kroemer, 1997;  Kane et al., 1993; Kroemer et al., 1997) . Because a previous report had suggested that KIT activation suppresses apoptosis in NK cells through an increase in bcl-2 levels (Carson et al., 1994), we investigated whether KIT activation might prevent p53-induced mitochondrial membrane depolarization and ROS production through an elevation of bcl-2 protein levels. As shown in Figure 5a , KIT activation has no eect on bcl-2 levels in Ts-DP16. Moreover, total bcl-2 protein levels remain the same following the temperature shift to 328C. This suggests that the mechanism by which KIT inhibits p53-dependent apoptosis is independent of bcl-2 protein levels.
Ectopic expression of the bcl-2 related protein Bax can induce apoptosis and DC m depolarization (Oltvai et al., 1993; Pastorino et al., 1998) . Because it has previously been reported that transcription of the Bax gene is regulated by p53 (Miyashita and Reed, 1995), we determined whether p53-mediated apoptosis in Ts-DP16 was associated with an increase in Bax protein, and whether KIT might suppress apoptosis and DC m depolarization by preventing Bax accumulation. As shown in Figure 5b , the total intracellular levels of Bax protein increases in Ts-DP16 cells undergoing apoptosis, consistent with the idea that Bax levels can be increased by p53. However, KIT activation has no eect on Bax levels, suggesting that KIT does not suppress apoptosis and DC m depolarization in Ts-DP16 cells through modulation of Bax protein levels.
KIT does not stabilize mitochondrial membrane potential through interaction with respiratory chain components
The drugs rotenone and oligomycin depolarize the mitochondrial membrane by preventing proton transport across the mitochondrial membrane. Rotenone inhibits mitochondrial electron transport complex I and oligomycin inhibits the mitochondrial ATP synthase. To determine if KIT could stabilize DC m through respiratory chain components, we measured the eect of Steel factor on rotenone and oligomycin induced DC m depolarization and apoptosis. As shown in Figure 6 , rotenone and oligomycin both decrease DC m (Figure 6a and b) and activate the nucleosomal laddering associated with apoptosis (Figure 6c and  d) . However, KIT activation has no aect on the ability of rotenone or oligomycin to induce apoptosis (Figure 6e and f) or decrease DC m in DP16 cells (Figure 6g, h) . The inability of KIT to rescue rotenone or oligomycin induced mitochondrial membrane depolarization or cell death suggests that KIT regulates apoptosis and mitochondrial function Figure 4 (a) KIT activation inhibits ROS production, measured by DCF¯uorescence. Incubation of Ts-DP16 cells at 328C leads to ROS production (D), which is inhibitable by 100 ng/ml Steel factor (^). ROS is not produced by parental DP16 incubated at 328C (&) or Ts-DP16 grown at 378C (*). Points are the average of three measurements. (b) Steel factor inhibits ROS generation in a dose dependent manner, 100 ng/ml Steel factor prevents ROS production 6 h after temperature shift, while 10 ng/ml Steel factor does not. ROS generation is measured relative to the untreated Ts-DP16 control, and is the mean and standard deviation of triplicate points Figure 5 Activation of KIT has no eect on total bcl-2 (a) or Bax (b) protein levels in Ts-DP16 cells lines grown at 328C with or without 100 ng/ml Steel factor. Total protein lysates of Ts-DP16 was collected at the indicated times following the temperature shift from 378C to 328C, and blotted with a monoclonal antibody against bcl-2 or Bax (Santa Cruz) independently of mitochondrial respiratory chain components.
Discussion
The KIT tyrosine kinase is a receptor of the PDGF superfamily which regulates mouse development in conjunction with its ligand, Steel factor (Bernstein et al., 1990; Besmer, 1991) . We and others have previously found that the activation of KIT can suppress p53-dependent apoptosis (Abrahamson et al., 1995; Lin and Benchimol, 1995) . Very little is known about the molecular mechanism by which p53 activates apoptosis. In this report we have found that p53-dependent apoptosis involves a depolarization of the mitochondrial DC m and the generation of reactive oxygen species. Preventing DC m depolarization has previously been found to inhibit p53-dependent apoptosis in other cell lines (Marchetti et al., 1996a; Polyak et al., 1997) . We have found that KIT inhibition of p53-dependent apoptosis involves a stabilization of the DC m and an inhibition of ROS generation, suggesting that these two processes are critical components of a p53-mediated death program. The ability of KIT to regulate DC m and ROS generation suggests that the KIT kinase could regulate development, at least in part, through the control of the mitochondria and intracellular redox state.
The mitochondria are central regulators of apoptosis. Mitochondria-enriched extracts from Xenopus oocytes undergoing apoptosis are sucient to induce chromatin condensation and shrinkage and fragmentation of isolated Xenopus nuclei, both hallmarks of apoptosis (Newmeyer et al., 1994) . Mitochondria likely activate apoptosis through the release of mitochondrial cytochrome c into the cytoplasm (Liu et al., 1996; Yang et al., 1997; Kluck et al., 1997a) . Cytoplasmic cytochrome c participates in the activation of caspases (Kluck et al., 1997b; Li et al., 1997) , a family of related cysteine proteases which cleave after aspartic acid residues (Salvesen and Dixit, 1997). Caspase activation is a universal and necessary feature of apoptosis, leading to the cleavage of enzymes regulating cell morphology, RNA processing, and DNA replication (Wen et al., 1997; Kothakota et al., 1997; Loetscher et al., 1997; Gu et al., 1995) . Mitochondria also contribute to apoptosis through the apoptosis-induced release of an uncharacterized 50 kDa protease AIF (AIF: apoptosis inducing factor) into the cytoplasm . AIF is sucient to induce chromatin condensation and nuclear laddering in a cell-free system .
The mechanism by which apoptosis-inducing signals cause cytochrome c and AIF release from the mitochondria are not clear. However, one of the earliest events in apoptotic cells is a decrease in DC m suggesting that DC m might regulate both cytochrome c and AIF release . A drop in DC m occurs during apoptosis induced by TNF, glucocorticoids, g-radiation, NGF withdrawal, and treatment with anti-Fas, anti-CD3, and anti-IgM antibodies . DC m disruption occurs in neurons, ®broblasts, T and B cells, thymocytes and hepatocytes. Drugs which lower DC m are sucient to induce apoptosis and inhibition of DC m depolarization by bongkrekic acid prevents apoptosis in thymocytes (Zamzami et al., 1995; Marchetti et al., 1996a) . These observations are consistent with the idea that apoptosis is regulated by a mitochondrial process intimately associated with the depolarization of DC m . However, apoptosis in Xenopus eggs is not accompanied by depolarization of the mitochondrial membrane (Kluck et al., 1997a) , suggesting that there may be DC m -independent pathways of apoptosis. We have found that p53-mediated apoptosis is associated with a depolarization of DC m . Inhibition of p53-mediated apoptosis by the KIT tyrosine kinase prevents p53-induced DC m depolarization. Thus, DC m depolarization is an essential part of p53-mediated apoptosis in Ts-DP16 cells.
The DC m is the result of the mitochondrial respiratory chain pumping protons from the mitochondrial matrix to the intermembrane space across the inner mitochondrial membrane. The electrochemical gradient thus generated is used to generate ATP through oxidative phosphorylation. The maintenance of the DC m requires that the inner mitochondrial membrane be impermeable to electrolytes and that the electron transport chain be intact and functioning. Thus, the apoptosis-induced depolarization of the mitochondrial DC m may be the result of a shutdown of electron transport or an increase in permeability of the inner mitochondrial membrane. Rotenone and oligomycin depolarize DC m by interfering with mitochondrial electron transport and concomitant proton translocation. Rotenone interferes with respiratory chain complex I, preventing it from oxidizing NADH and transporting one proton across the inner mitochondrial membrane. Oligomycin inhibits the ATP generation by inhibiting ATP synthase and indirectly preventing electron transport because of the obligate coupling of ATP production and electron transport. We have found that both rotenone and oligomycin can decrease DC m and induce apoptosis in DP16. The ability of both drugs to induce apoptosis in DP16, concomitant with a depolarization of the DC m , adds further weight to the idea that the DC m is a key apoptotic regulator. The inability of KIT to prevent rotenone and oligomycin-induced apoptosis and DC m depolarization suggests that KIT does not regulate mitochondrial DC m through control of electron transport or ATP synthase activity. It seems more likely that KIT regulates the permeability of the mitochondrial membrane.
In isolated mitochondria, the ion permeability of the inner membrane is regulated by permeability transition (PT) pores (Bernardi et al., 1994; Zoratti and Szabo, 1995) . Once opened, PT pores make the inner mitochondrial membrane permeable to solutes 51.5 kDa, leading to a decrease in DC m as protons pass into the mitochondrial matrix. Little is known about the structure and molecular composition of PT pores. The adenine nucleotide translocator (ANT) inner mitochondrial protein is involved in PT pore formation through interactions with proteins in the outer mitochondrial membrane (Zoratti and Szabo, 1995) . ANT ligands, including the mitochondrial benzodiazepine receptor and cyclophilin regulate PT pore formation. Protoporphyrin IX (PPIX), a mitochondrial benzodiazepine receptor ligand and PT pore promoter, induces apoptosis and DC m depolarization in thymocytes and T cells . In addition, the PT inhibitor and ANT ligand, bongkrekic acid, has the opposite eect of PPIX, and inhibits dexamethasone and g-irradiation-induced thymocyte apoptosis . Thus, PT pore formation is both necessary and sucient for some forms of apoptosis. The ability of p53 to depolarize DC m suggests that PT pore formation can be regulated by p53. Furthermore, the ability of KIT to halt p53-dependent DC m deplorization and concomitant apoptosis in DP16 suggests the KIT directly or indirectly can regulate PT pore formation or function.
In our DP16 cells line, the activation of p53 leads to a decrease in DC m as well as the production of reactive oxygen species (ROS). The role of ROS in apoptosis is controversial: ROS production is important in some, but not all forms of apoptosis (Buttke and Sandstrom, 1994; Um et al., 1996) . The regulation of cellular redox levels may be crucial to p53-dependent apoptosis and many of the genes activated by p53 are involved in oxidative metabolism (Polyak et al., 1997) . TNF-a-and dexamethasone-induced apoptosis requires generation of ROS (Schulze-Ostho et al., 1992 , and anti-oxidants can prevent various types of apoptotic death (Buttke and Sandstrom, 1994) . ROS could lead to apoptosis through ROS-mediated DNA damage, lipid peroxidation and protein destruction. However, ROS generation is not required for all types of apoptosis, and cells depleted of O 2 to reduce ROS generation are still capable of undergoing apoptosis (Jacobson and Ra, 1995) . The generation of ROS in Ts-DP16 at 328C suggests that ROS is part of the p53-dependent death process. The mechanism by which p53 and other apoptosis-inducing signals increase ROS production is not well characterized, but might involve DC m depolarization . Alternatively, there may be a non-mitochondrial source for ROS generation during p53-dependent apoptosis. Apoptosis inducing agents may decrease free radical scavenging, increase intra-cellular metal levels, or may alter the activity of the mitochondrial electron transport chain, which is the source of most of the intracellular ROS. The ability of KIT to suppress ROS generation suggests that one or all of these pathways is subject to kinase regulation. If ROS generation is regulated by DC m , then KIT could control ROS though the PT pore.
Bcl-2 is a protein found on the mitochondrial outer membrane and ectopic overexpression of bcl-2 prevents multiple forms of apoptosis as well as mitochondrial DC m depolarization and ROS production (Kane et al., 1993) . The mechanism by which bcl-2 prevents these processes is not well understood, but may involve the regulation and creation of ion pores in the outer mitochondrial membrane (Reed, 1997; Schendel et al., 1997) . In natural killer (NK) cells, KIT inhibits apoptosis by increasing in bcl-2 protein levels (Carson et al., 1994) . In Ts-DP16, however, KIT suppresses apoptosis without altering bcl-2 levels. Thus, KIT is likely to inhibit apoptosis by at least two mechanisms, one aecting bcl-2 levels and the other not. However, the regulation of bcl-2 activity is likely to involve more than just bcl-2 protein levels, since bcl-2 activity is aected by interactions with and the protein levels of other bcl-2 family members (Kroemer, 1997; Reed, 1994) .
The Bax protein is a bcl-2 family member whose overexpression induces apoptosis as well as depolarising the mitochondrial DC m (Oltvai et al., 1993; Pastorino et al., 1998) . Bax is believed to regulate these processes by forming an ion pore in the mitochondrial membrane which allows escape of mitochondrial cytochrome c and/or protons into the cytosol Reed, 1997) . Transcription of the Bax gene is directly regulated by p53 (Miyashita and Reed, 1995) , and we have found that Bax protein levels increase in Ts-DP16 cells during p53-mediated apoptosis. However, KIT has no eect on Bax levels, suggesting that if Bax is critical in p53-dependent apoptosis, KIT must suppress apoptosis independent of intracellular Bax levels.
KIT could regulate mitochondrial function by altering the phosphorylation of the Bcl-2 protein. The bcl-2 protein can be phosphorylated by the JNK, PKC and possibly raf-1 kinases Ito et al., 1997; Wang et al., 1996; Haldar et al., 1995) , but the role of bcl-2 phosphorylation in its functional regulation is controversial. Phosphorylation of bcl-2 residues may be involved in either activation or suppression of apoptosis (Haldar et al., 1995; Wen et al., 1997) . Alternatively, KIT may regulate apoptosis by altering the phosphorylation of the BAD protein. BAD is a bcl-2 related protein which induces apoptosis by binding to and inhibiting the function of the bcl-2 related protein Bcl-x L (Yang et al., 1995) . Bcl-x L inhibits apoptosis by binding to the apoptosis promoter Bax and preventing Bax from inhibiting the function of bcl-2. Bcl-x L may also increase the activity of bcl-2. The interaction between BAD and Bcl-x L is regulated by phosphorylation of BAD serine residues 112 and 136 (Zha et al., 1996) . Phosphorylation of these sites leads to sequestration of BAD by 14-4-3 proteins, preventing BAD/Bcl-x L interaction, eectively inhibiting apoptosis (Zha et al., 1996) . The kinase responsible for phosphorylating BAD is Akt, a kinase which is activated by PI-3 kinase (del Peso et al., 1997) . Activation of the IL-3 receptor (IL-3R), an inhibitor of apoptosis, leads to phosphorylation of BAD by a pathway involving the sequential activation of PI-3k and Akt (Zha et al., 1996; del Peso et al., 1997) . Like IL-3R, KIT is also capable of activating PI-3K . Thus, by analogy with the IL-3R, KIT activation may lead to an increase in bcl-2 activity though PI-3K, Akt and BAD. Further investigation into KIT-dependent signaling pathways is likely to shed further light into KIT regulation of apoptosis and mitochondrial function.
Materials and methods
Cell lines and viability
The Friend erythroleukemia cell line DP16 is derived from the spleen of a DBA/2J mouse infected with the polycythemia strain of Friend erythroleukemia virus. The derivation of Ts-DP16 has been previously reported (Abrahamson et al., 1995) . Cell lines were maintained in Dulbeco's modi®ed minimal essential medium supplemented with 10% fetal bovine serum (GIBCO). Cells were grown at either 378C or 328C in 5% CO 2 in 95% humidity. Cell viability was determined by trypan blue exclusion. Rotenone and oligomycin were both from SIGMA.
Mitochondrial membrane potential measurement
Ts-DP16 cell lines were resuspended at 1610 6 /ml in room temperature PBS, and 1 ml of the cells placed in an eppendorf tube. Rhodamine 123 (Rh123; Sigma, St Louis, MO) was added to a ®nal concentration of 2 mM from a 1 mM Rh123 stock in water. Samples were incubated at 378C for 30 min and then analysed on a Coulter EPICS II-PROFILĒ ow cytometer. For ®gures in this paper,¯ow cytometry printouts were scanned into Adobe Photoshop 3.0 using a Hewlett-Packard 4P scanner and redrawn onto new axes.
ROS measurement
One hundred ml of Ts-DP16 in 20 mM HEPES (pH 7.4), 10 mM dextrose, 127 mM NaCl, 5.5 mM KCl, 1 mM CaCl 2 , 2 mM MgSO 4 were plated with and without Steel factor at 10 5 per well in a 96 well Nunc tissue culture plate. 2',7'-dichlorodihydro¯uoresceindiacetate (DCF) (Molecular Probes, OR) was added to 1 mg/ml and¯uorescence measured in a Cyto¯uor 2300 at an excitation wavelength of 485 nm and an emission wavelength of 530 nm,
DNA fragmentation analysis
1610
6 Ts-DP16 cells were spun at 14 000 g for 10 s and the media aspirated. Cells were resuspended in 200 ml of 100 mM Tris (pH 7.5), 10 mM EDTA, 100 mM NaCl, 0.5% SDS and 10 mg/ml proteinase K and incubated at 558C overnight. Extracts were electrophoresed on a 1.5% agarose gel, stained with ethidium bromide and visualized under UV light and photographed using a Stratagene EagleEye video camera.
Western blotting 1610 6 DP16 cells were lysed directly in 100 ml of 16reducing SDS sample buer (NEB) and incubated at 1008C for 5 min. Twenty ml of the boiled extract was run on a 12% polyacrylamide gel, transferred to nitrocellulose (S&S) using a BioRad semi-dry transfer apparatus. The blot was then incubated with an antibody against bcl-2 (Santa Cruz) as per the manufacturers directions.
